Skip to content Skip to footer

2026

Journal Article

Mitoses counting in phyllodes tumours: rationale for a standardized hotspot‐based approach

Hadi, Edward, Gudi, Mihir, Li, Bill, O'Toole, Sandra, Ryska, Ales, Tse, Gary, Lakhani, Sunil, Schnitt, Stuart, Ellis, Ian, Rakha, Emad and Tan, Puay Hoon (2026). Mitoses counting in phyllodes tumours: rationale for a standardized hotspot‐based approach. Histopathology his.70293. doi: 10.1111/his.70293

Mitoses counting in phyllodes tumours: rationale for a standardized hotspot‐based approach

2026

Conference Publication

LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?

Reed, Amy McCart, Kalinowski, Lauren, Maklouf, Shorouk, Djerroudi, Lounes, McLaren, Alexandra, Beecher, Kate, Lal, Samir, Kutasovic, Jamie, Srihari, Sriganesh, Feng, Yufan, Ferguson, Kaltin, Chittoory, Haarika, Sokolova, Anna, Lim, Malcolm, Salomon, Carlos, Porter, Alan, Evans, Elizabeth, Rakha, Emad, Edwards, Joanne, Salomon, Anne, Lakhani, Sunil and Simpson, Peter (2026). LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?. International Invasive Lobular Carcinoma Symposium, San Francisco Ca, Sep 23-25, 2026. NEW YORK: SPRINGER.

LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?

2026

Journal Article

Lobular breast cancer and prognosis: what should we tell patients?

Kulasegaran, Tivya, Beecher, Kate, Kinnon, Pamela, Lakhani, Sunil R., Simpson, Peter T. and McCart Reed, Amy E. (2026). Lobular breast cancer and prognosis: what should we tell patients?. Frontiers in Oncology, 16 1877790. doi: 10.3389/fonc.2026.1877790

Lobular breast cancer and prognosis: what should we tell patients?

2026

Journal Article

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies

Adams, Daniel, Hurson, Amber N., Ahearn, Thomas U., Andrulis, Irene L., Antoniou, Antonis C., Auvinen, Paivi, Bane, Anita, Behrens, Sabine, Berrington de Gonzalez, Amy, Bialkowska, Katarzyna, Bodelon, Clara, Bolla, Manjeet K., Borrero, Maria, Brenner, Hermann, Brock, Ian W., Broeks, Annegien, Camp, Nicola J., Cessna, Melissa H., Chanock, Stephen J., Chenevix-Trench, Georgia, Copson, Ellen, Couch, Fergus J., Cox, Angela, Cross, Simon S., Devilee, Peter, Dunning, Alison M., Easton, Douglas F., Eccles, Diana M., Figueroa, Jonine D. ... Garcia-Closas, Montserrat (2026). Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies. Jnci-Journal of the National Cancer Institute djag244. doi: 10.1093/jnci/djag244

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies

2026

Journal Article

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial

Garber, J.E., Cameron, D., Campbell, C., Yothers, G., Taboada, M., El-abed, S., Rastogi, P., McConnell, R., Correa, A., Delaloge, S., Liu, W.T., Sharma, P., Bergh, J., Janni, W., Balmaña, J., Loman, N., Španić, T., Friedman, S., Freeman, T., Armstrong, A., Korde, L., Im, S., Sagara, Y., Viale, G., Bliss, J., Gianni, L., Jóhannsson, Ó., Zoppoli, G., De Dueñas, E. Martinez ... Tutt, A.N.J. (2026). Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial. Annals of Oncology. doi: 10.1016/j.annonc.2026.08.002

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial

2026

Conference Publication

Investigating STING in Breast Cancer Brain Metastasis

Joshi, Vaibhavi, Beecher, Kate, Duijf, Pascal, Stacey, Andrew, Druskovich, Sam, Reed, Sarah, Simpson, Peter, Lakhani, Sunil and McCart Reed, Amy (2026). Investigating STING in Breast Cancer Brain Metastasis. European Association of Cancer Research Annual Congress, Budapest, Hungary, 8-11 June 2026.

Investigating STING in Breast Cancer Brain Metastasis

2026

Journal Article

Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

Fernandez, Kristine J., Sultani, Ghazal, Nobis, Max, Gloss, Brian, Eshraghi, Leila, McCart Reed, Amy E., Alexandrou, Sarah, Lee, Christine, Roden, Daniel L., Jones, Emily I., Simad, Maryam Hasha, Millar, Ewan K. A., Bartonicek, Nenad, Oakes, Samantha R., Valdes-Mora, Fatima, Colino-Sanguino, Yolanda, Mok, Ellie T. Y., Williams, Hannah L., Kutasovic, Jamie R., Cummings, Margaret C., Stoehr, Janett, Lee, Victoria, Harvey, Kate, Wu, Sunny, Lakhani, Sunil R., Simpson, Peter T., Cox, Thomas R., Ooms, Lisa M., Mitchell, Christina A. ... Caldon, C. Elizabeth (2026). Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling. Nature Communications, 17 (1) 3042, 1-23. doi: 10.1038/s41467-026-70683-x

Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

2026

Journal Article

World Health Organization classification of tumours of the breast 6th edition 2026

Quinn, Cecily, Tan, Puay Hoon, Allison, Kimberly H, Brogi, Edi, Lakhani, Sunil R, Schnitt, Stuart J, Fox, Stephen B, Jaffer, Shabnam, Sahin, Aysegul, Salgado, Roberto, Sapino, Anna, Adjei, Ernest Kwasi, Geiersbach, Katherine, Helbich, Thomas H, Lambertini, Matteo, Sotiriou, Christos, Hodge, Jennelle C, Khoury, Joseph D, Rekhi, Bharat, Ryska, Ales, Tse, Gary, Field, Andrew, Wijesinghe, Harshima, Puspanathan, Pavitratha, Giesen, Christine, Ruiz, Blanca Iciar Indave, Ellis, Ian, Lokuhetty, Dilani and WCT Standing Editorial Board (2026). World Health Organization classification of tumours of the breast 6th edition 2026. Histopathology, 89 (2) his.70149, 199-218. doi: 10.1111/his.70149

World Health Organization classification of tumours of the breast 6th edition 2026

2026

Journal Article

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification

Fortuno, Cristina, Zhang, Jia, Koufariotis, Lambros T., Hollway, Georgina, Wood, Scott, Pearson, John V., Simpson, Peter T., Lakhani, Sunil R., Reed, Amy E. Mccart, Thorne, Heather, Mann, G. Bruce, Skandarajah, Anita R., Devereux, Lisa, Zhao, Qihong, Silva, Dilanka L. De, Lindeman, Geoffrey J., Waring, Paul, James, Paul A., Campbell, Ian, Spurdle, Amanda B. and Waddell, Nicola (2026). Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. Ebiomedicine, 126 106199, 1-14. doi: 10.1016/j.ebiom.2026.106199

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification

2026

Conference Publication

Improving Diagnostic Reproducibility of Invasive Lobular Carcinoma: A Proposal for a New Architecture-Based Classification

Djerroudi, Lounes, De Schepper, Maxim, Lakhani, Sunil, Pareja, Fresia, Derksen, Patrick, Brogi, Edi, Schnitt, Stuart, Floris, Giuseppe and Vincent-Salomon, Anne (2026). Improving Diagnostic Reproducibility of Invasive Lobular Carcinoma: A Proposal for a New Architecture-Based Classification. 115th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), San Antonio Tx, Mar 21-26, 2026. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.labinv.2025.104403

Improving Diagnostic Reproducibility of Invasive Lobular Carcinoma: A Proposal for a New Architecture-Based Classification

2026

Journal Article

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

Nones, Katia, Lakis, Vanessa, Dalley, Andrew J., Ryan, Kimberley, Chittoory, Haarika, Ferguson, Kaltin, Fitzgerald, Kate, Newell, Felicity, Koufariotis, Lambros T., Bashirzadeh, Farzad, Son, Jung Hwa, Singh, Mahendra, Nandakumar, Lakshmy, Fairbairn, David, Cummings, Margaret, Steinfort, Daniel, Christie, Jemma J., Gibney, Matthew, Williamson, Jonathan P., Pattison, Andrew, McIntosh, Louise, Pahoff, Carl, Nguyen, Phan Tien, Solujic, Jelena, Brown, Michael, Twaddell, Scott, Arnold, David, Grainge, Christopher, Gune, Shailendra ... Fielding, David (2026). Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities. Genome Medicine, 18 (1) 47. doi: 10.1186/s13073-026-01624-y

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

2026

Journal Article

Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy

Wong, Joshua K. M., Lam, Pui Yeng, Coleborn, Elaina, Alim, Louisa, Jose, Jiya, Tu, Cui, Antczak, Magdalena, Dietmair, Bettina, Hagh, Arghavan Golbaz, Noronha, Lucia, Cheetham, Seth W., Hooper, John, Beavis, Paul A., Merino, Delphine, Berthelet, Jean, Aoude, Lauren G., McCart-Reed, Amy E., Lakhani, Sunil, Simpson, Peter T., Rossi, Gustavo R., Brooks, Andrew J., Jones, Martina L., Simpson, Fiona and Souza-Fonseca-Guimaraes, Fernando (2026). Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Molecular Therapy, 34 (3), 1382-1398. doi: 10.1016/j.ymthe.2025.11.021

Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy

2026

Journal Article

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines

Momeny, Majid, Saunus, Jodi M., Marturana, Flavia, Reed, Amy E. McCart, Black, Debra, Sala, Gianluca, Iacobelli, Stefano, Holland, Jane D., Yu, Dihua, Da Silva, Leonard, Simpson, Peter T., Khanna, Kum Kum, Chenevix-Trench, Georgia and Lakhani, Sunil R. (2026). Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget, 17 (1). doi: 10.18632/oncotarget.28900

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines

2026

Journal Article

Trastuzumab deruxtecan for HER2-Low metastatic breast cancer: practical considerations for medical oncologists and pathologists in Australia

Redfern, Andrew, Lim, Elgene, Lakhani, Sunil, Pathmanathan, Nirmala, Selva-Nayagam, Sudarsha, McCarthy, Nicole, Yeo, Belinda, Dessauvagie, Benjamin and Farshid, Gelareh (2026). Trastuzumab deruxtecan for HER2-Low metastatic breast cancer: practical considerations for medical oncologists and pathologists in Australia. Asia-Pacific Journal of Clinical Oncology, 22 (3), 381-391. doi: 10.1111/ajco.70069

Trastuzumab deruxtecan for HER2-Low metastatic breast cancer: practical considerations for medical oncologists and pathologists in Australia

2026

Book Chapter

The breast

Sokolova, Anna, Simpson, Peter T. and Lakhani, Sunil R. (2026). The breast. Robbins, Cotran & Kumar pathologic basis of disease. (pp. 944-969) edited by Jon C. Aster, Abul K. Abbas, Vinay Kumar, Jayanta Debnath and Abhijit Das. Philadelphia, PA United States: Elsevier.

The breast

2025

Journal Article

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

Kader, Tanjina, Zethoven, Maia, Mahale, Sakshi, Saunders, Hugo, Tjoeka, Lauren, Lehmann, Rebecca, Jayawardana, Madawa W., Pang, Jia-min, Lesche, Dorothea, Rajan, Neeha, Semple, Timothy, Lee, Jue Er Amanda, Lupat, Richard, Byrne, David J., Hughes, Siobhan, Nguyen, Hoa, Lai, Siqi, Pechlivanis, Maree, Craig, Olivia, Devereux, Lisa, House, Eloise, Jayasinghe, Sureshni, Kaufmann, Tom L., Schwarz, Roland F., Green, Andrew R., Miligy, Islam M., Cummings, Margaret, Lakhani, Sunil, Campbell, Ian G. ... Gorringe, Kylie L. (2025). Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. Journal of Pathology, 268 (1) path.6461, 1-12. doi: 10.1002/path.6461

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

2025

Journal Article

Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneity

Feng, Yufan, Xiong, Albert, Mulay, Onkar, Sokolova, Anna, Lim, Malcolm, Van Haeringen, Benjamin, McGuire, Natasha, de Luca, Xavier, Simpson, Peter T., Nguyen, Quan, Lakhani, Sunil R. and McCart Reed, Amy E. (2025). Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneity. npj Breast Cancer, 11 (1) 89. doi: 10.1038/s41523-025-00807-x

Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneity

2025

Conference Publication

Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast

Wong, Clarissa Jing Wen, Nasir, Nur Diyana Md, Koh, Valerie Cui Yun, Campbell, Fiona, Fox, Stephen, Lakhani, Sunil R., Myles, Nickolas, Yip, George, Colling, Richard, Cree, Ian A., Lokuhetty, Dilani and Tan, Puay Hoon (2025). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.FCS2024-P78

Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast

2025

Journal Article

Genomic predictive biomarkers in breast cancer: the haves and have nots

Beecher, Kate, Kulasegaran, Tivya, Lakhani, Sunil R. and McCart Reed, Amy E. (2025). Genomic predictive biomarkers in breast cancer: the haves and have nots. International Journal of Molecular Sciences, 26 (15) 7300, 7300-15. doi: 10.3390/ijms26157300

Genomic predictive biomarkers in breast cancer: the haves and have nots

2025

Conference Publication

Multi-omic explainable machine learning improves cancer treatment outcome prediction

Tran, Khoa A., Addala, Venkateswar, Koufariotis, Lambros T., Zhang, Jia, Wood, Scott, Leonard, Conrad, Hoeijmakers, Lotte L., Blank, Christian U., Crispin-Ortuzar, Mireia, McCart. Reed, Amy, Inglis, Po-ling, Lakhani, Sunil R., Williams, Elizabeth D., Pearson, John V., Kondrashova, Olga and Waddell, Nicola (2025). Multi-omic explainable machine learning improves cancer treatment outcome prediction. AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, Montreal, QC Canada, 10-12 July 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1557-3265.aimachine-a051

Multi-omic explainable machine learning improves cancer treatment outcome prediction